Patents Assigned to Biosystems Inc.
  • Patent number: 12385009
    Abstract: Methods for generating pre-oligodendrocyte progenitor cells (pre-OPCs) and oligodendrocyte progenitor cells (OPCs) from human pluripotent stem cells are provided using chemically-defined culture media that allow for generation of pre-OPCs and OPCs in as little as three days. Culture media, isolated cell populations and kits are also provided.
    Type: Grant
    Filed: January 28, 2022
    Date of Patent: August 12, 2025
    Assignee: Trailhead Biosystems Inc.
    Inventor: Nooshin Amini
  • Publication number: 20250235862
    Abstract: This disclosure provides methods and apparatuses for sorting target particles. In various embodiments, the disclosure provides a cassette for sorting target particles, methods for sorting target particles, methods of loading a microchannel for maintaining sample material viability, methods of quantifying sample material, and an optical apparatus for laser scanning and particle sorting.
    Type: Application
    Filed: January 10, 2025
    Publication date: July 24, 2025
    Applicant: Orca Biosystems, Inc.
    Inventors: Ivan K. Dimov, Nathaniel Fernhoff, Lagnajeet Pradhan
  • Patent number: 12359190
    Abstract: The present disclosure relates to fluidic systems and devices for processing, extracting, or purifying one or more analytes. These systems and devices can be used for processing samples and extracting nucleic acids, for example by isotachophoresis. In particular, the systems and related methods can allow for extraction of nucleic acids, including non-crosslinked nucleic acids, from samples such as tissue or cells. The systems and devices can also be used for multiplex parallel sample processing.
    Type: Grant
    Filed: August 8, 2023
    Date of Patent: July 15, 2025
    Assignee: Purigen Biosystems, Inc.
    Inventors: Lewis A. Marshall, Amy L Hiddessen, Nathan P. Hoverter, Klint A. Rose, Juan G. Santiago, Matthew S. Munson, Janine Mok, Sean Arin, Yatian Qu, Andrew Lee, Michael Christopher De Renzi
  • Patent number: 12264315
    Abstract: The present disclosure provides a method for enrichment of at least one target nucleic acid in a library of nucleic acids. A first oligonucleotide is hybridized to a target nucleic acid in library of nucleic acids having first and second adapters. The hybridized first oligonucleotide is extended with a first polymerase, thereby producing a first primer extension complex including the target nucleic acid and the extended first oligonucleotide. The first primer extension complex is captured, enriched relative to the library of nucleic acids, and a second oligonucleotide is hybridized to the target nucleic acid. The hybridized second oligonucleotide is extended with a second polymerase, thereby producing a second primer extension complex including the target nucleic acid and the extended second oligonucleotide, and further liberating the extended first oligonucleotide from the first primer extension complex.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: April 1, 2025
    Assignees: Roche Sequencing Solutions, Inc., Kapa Biosystems, Inc.
    Inventors: Daniel Burgess, Brian Christopher Godwin, Alexander Lovejoy, Bronwen Miller, Jo-Anne Elizabeth Penkler, Joseph Platzer, Martin Ranik
  • Patent number: 12256957
    Abstract: Disclosed herein are apparatuses, systems, kits, and methods for treating skin, such as skin tightening or for treating diseases, disorders, and conditions that would benefit from tissue area or volume reduction, skin restoration, skin tightening, skin lifting, and/or skin repositioning and/or for generally improving skin function or appearance (e.g., the removal of unwanted skin features or irregularities such as sebaceous glands, sweat glands, hair follicles, necrosis, and fibrosis). Such apparatuses, systems, kits, and methods comprise an apparatus having a handheld main body and a detachably attachable tip comprising one or more needles.
    Type: Grant
    Filed: January 5, 2024
    Date of Patent: March 25, 2025
    Assignee: Cytrellis Biosystems, Inc.
    Inventors: Alec Ginggen, Douglas Levinson
  • Patent number: 12226770
    Abstract: This disclosure provides methods and apparatuses for sorting target particles. In various embodiments, the disclosure provides a cassette for sorting target particles, methods for sorting target particles, methods of loading a microchannel for maintaining sample material viability, methods of quantifying sample material, and an optical apparatus for laser scanning and particle sorting.
    Type: Grant
    Filed: August 4, 2023
    Date of Patent: February 18, 2025
    Assignee: Orca Biosystems, Inc.
    Inventors: Ivan K. Dimov, Nathaniel Fernhoff, Lagnajeet Pradhan
  • Patent number: 12150671
    Abstract: Disclosed herein are methods, apparatuses, and devices for treating skin, such as skin tightening or for treating diseases, disorders, and conditions that would benefit from tissue area or volume reduction, skin restoration, skin tightening, skin lifting, or skin repositioning. Such methods and devices include an ablative apparatus, a removal apparatus, and/or a positioning apparatus.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: November 26, 2024
    Assignee: Cytrellis Biosystems, Inc.
    Inventors: Alec Ginggen, Douglas Levinson, David Stone
  • Patent number: 12110534
    Abstract: The invention is a novel method of sequencing nucleic acids involving making and sequencing a library of single stranded circular target nucleic acids.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: October 8, 2024
    Assignees: Roche Sequencing Solutions, Inc., Kapa Biosystems, Inc.
    Inventors: Daleen Badenhorst, Michael S. Berry, Richard Dannebaum, Ashley Hayes, Severine Margeridon, Martin Ranik, Etienne Slabbert
  • Patent number: 12077810
    Abstract: The invention features methods, systems, and cartridges for amplification of target nucleic acids in complex samples, for example, whole blood. The invention also features diagnostic and therapeutic methods based on amplification of target nucleic acids characteristic of pathogens present in complex samples containing cells and/or cell debris, for example, whole blood.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: September 3, 2024
    Assignee: T2 Biosystems, Inc.
    Inventors: Ulrich Hans Thomann, Jessica Lee Snyder, Thomas Jay Lowery, Jr.
  • Publication number: 20240261442
    Abstract: This invention relates to a method to assess nodal disease by magnetic resonance imaging with a contrast agent. The contrast agent comprises biofunctional magnetic nanoparticles coated with polymers outside the iron core and conjugated with antibodies specific to the tumor type to be assessed. Images produced from this magnetic resonance imaging with a contrast agent show heterogenous hypo intensity or heterogenous architecture in regions where binding by the antibodies is present.
    Type: Application
    Filed: February 2, 2024
    Publication date: August 8, 2024
    Applicant: Imagion Biosystems, Inc.
    Inventors: Robert PROULX, Yalia JAYALAKSHMI, Marie ZHANG, Natalie YANG, Wing Fai LAU
  • Patent number: 12011461
    Abstract: The present disclosure provides distinct therapeutic populations of cells that form a pharmaceutical composition useful in hematopoietic stem/progenitor cell transplant. For example, the present disclosure provides a therapeutic population of cells, comprising an enriched population of hematopoietic stem/progenitor cells, memory T cells, regulatory T cells, and wherein the population of cells is depleted of naïve conventional ??-T cells. The present disclosure further provides methods of treatment using the therapeutic population of cells. In other embodiments, the present disclosure provides methods of producing a therapeutic population of cells.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: June 18, 2024
    Assignee: Orca Biosystems, Inc.
    Inventors: Ivan K. Dimov, Nathaniel Fernhoff, Kevin Sheehan
  • Patent number: 12014835
    Abstract: The invention provides methods for evaluating the therapeutic benefit of a combination therapy useful for treating a medical disorder, such as cancer.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: June 18, 2024
    Assignees: Vanderbilt University, Duet BioSystems Inc.
    Inventors: Christian T. Meyer, Vito Quaranta, Leonard A. Harris, Buddhi Bishal Paudel, David J. Wooten, Laurent Audoly
  • Patent number: 12006496
    Abstract: The present disclosure relates to fluidic systems and devices for processing, extracting, or purifying one or more analytes. These systems and devices can be used for processing samples and extracting nucleic acids, for example by isotachophoresis. In particular, the systems and related methods can allow for extraction of nucleic acids, including non-crosslinked nucleic acids, from samples such as tissue or cells. The systems and devices can also be used for multiplex parallel sample processing.
    Type: Grant
    Filed: May 1, 2023
    Date of Patent: June 11, 2024
    Assignee: Purigen Biosystems, Inc.
    Inventors: Lewis A. Marshall, Amy L. Hiddessen, Nathan P. Hoverter, Klint A. Rose, Juan G. Santiago
  • Patent number: 11987789
    Abstract: The present disclosure relates to fluidic systems and devices for processing, extracting, or purifying one or more analytes. These systems and devices can be used for processing samples and extracting nucleic acids, for example by isotachophoresis. In particular, the systems and related methods can allow for extraction of nucleic acids, including non-crosslinked nucleic acids, from samples such as tissue or cells. The systems and devices can also be used for multiplex parallel sample processing.
    Type: Grant
    Filed: April 14, 2021
    Date of Patent: May 21, 2024
    Assignee: Purigen Biosystems, Inc.
    Inventors: Lewis A. Marshall, Amy L. Hiddessen, Nathan P. Hoverter, Klint A. Rose, Juan G. Santiago, Matthew S. Munson, Janine Mok, Sean Arin, Yatian Qu, Andrew Lee, Michael Christopher De Renzi
  • Patent number: 11953561
    Abstract: Example embodiments of the present invention provide a magnetic relaxometry measurement apparatus, comprising: a magnetizing system configured to supply a pulsed magnetic fields to a sample; a sensor system configured to detect magnetic fields produced by induced magnetization of the sample after a magnetic field pulse from the magnetizing system; one or more compensating coils configured to suppress generation of eddy currents in an environment surrounding the apparatus due to the pulsed magnetic fields.
    Type: Grant
    Filed: December 8, 2022
    Date of Patent: April 9, 2024
    Assignee: Imagion Biosystems, Inc.
    Inventors: Todor Karaulanov, Giulio D Paciotti
  • Publication number: 20240075471
    Abstract: This disclosure provides methods and apparatuses for sorting target particles. In various embodiments, the disclosure provides a cassette for sorting target particles, methods for sorting target particles, methods of loading a microchannel for maintaining sample material viability, methods of quantifying sample material, and an optical apparatus for laser scanning and particle sorting.
    Type: Application
    Filed: August 4, 2023
    Publication date: March 7, 2024
    Applicant: Orca Biosystems, Inc.
    Inventors: Ivan K. Dimov, Nathaniel Fernhoff, Lagnajeet Pradhan
  • Patent number: 11896261
    Abstract: Disclosed herein are apparatuses, systems, kits, and methods for treating skin, such as skin tightening or for treating diseases, disorders, and conditions that would benefit from tissue area or volume reduction, skin restoration, skin tightening, skin lifting, and/or skin repositioning and/or for generally improving skin function or appearance (e.g., the removal of unwanted skin features or irregularities such as sebaceous glands, sweat glands, hair follicles, necrosis, and fibrosis). Such apparatuses, systems, kits, and methods comprise an apparatus having a handheld main body and a detachably attachable tip comprising one or more needles.
    Type: Grant
    Filed: March 31, 2022
    Date of Patent: February 13, 2024
    Assignee: Cytrellis Biosystems, Inc.
    Inventors: Alec Ginggen, Douglas Levinson
  • Patent number: 11898204
    Abstract: The invention is a novel method of separately sequencing each strand of a nucleic acid involving the use of an adaptor comprising a strand cleavage site or a strand synthesis termination site. The adaptor may also be self-priming at the strand cleavage site.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: February 13, 2024
    Assignees: Roche Sequencing Solutions, Inc., KAPA Biosystems, Inc.
    Inventors: Aruna Arcot, Daleen Badenhorst, Rui Chen, Toummy Guettouche, Ashley Hayes, Jenny A. Johnson, Severine Margeridon, Martin Ranik, Persis Wadia, Alexandra Hui Wang
  • Patent number: D1028275
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: May 21, 2024
    Assignee: T2 Biosystems, Inc.
    Inventors: Adam Suchocki, Steven Anthony Scampini, Joseph Antocci, Thomas Cygan, William Peine, Uli Thomann, Chris Werner
  • Patent number: D1051422
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: November 12, 2024
    Assignee: T2 Biosystems, Inc.
    Inventors: Vasiliki Demas, Trevor Beckett, Michael Withers, Robin Lee, Parris S. Wellman